• Chlorambucil Assays: From Crosslinks to Cell Fate

  2026-08-12

  Chlorambucil research is most informative when DNA damage, growth arrest, and cell death are measured as related but distinct outcomes. This guide applies a quantitative viability framework to assay design, model selection, and interpretation across leukemia and solid-tumor systems.

• Catalpol Activates Sirt6–ERα–FasL in Osteoporosis

  2026-08-11

  The reference study shows that catalpol protects ovariectomized rats from estrogen deficiency-induced osteoporosis by promoting osteoclast apoptosis through the Sirt6–ERα–FasL axis. Its combination of micro-CT, cellular assays, gene silencing, and protein-interaction analysis links improved bone architecture to a specific apoptotic mechanism rather than to osteoclast suppression alone.

• 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) Guide

  2026-08-11

  1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is a helper phospholipid used to promote endosomal membrane fusion in nucleic acid delivery systems. The C4956 product is a crystalline, ≥98% pure DOPE material with defined solvent-solubility and storage requirements.

• Aprotinin: From Protease Control to Translational Insight

  2026-08-10

  A mechanistic and strategic guide to using Aprotinin, or bovine pancreatic trypsin inhibitor, to interrogate fibrinolysis, inflammation, cardiovascular surgery blood management, and nascent transcription in translational research.

• v-Agatoxin-IVA: Low-Affinity N-Type Ca²⁺ Blockade

  2026-08-09

  Sidach and Mintz showed that v-Agatoxin-IVA is highly selective for P-type calcium channels at high affinity but can also incompletely inhibit neuronal N-type currents at micromolar exposure. The study demonstrates why toxin sensitivity must be interpreted alongside voltage dependence, gating kinetics, cell type, and orthogonal pharmacology rather than treated as a binary channel-class marker.

• MaMT4 Selectivity in Mulberry DNJ Biosynthesis

  2026-08-08

  A 2026 study identifies MaMT4 as a mulberry methyltransferase that switches between C2 methylation of piperidine and N-methylation of piperidin-4-ol according to substrate structure. Kinetic, genetic, docking, and mutational analyses link this unusual C/N selectivity to residues F363 and I80, providing a mechanistic framework for engineering DNJ-type alkaloid biosynthesis.

• Dual-Action p38α Inhibition and Dephosphorylation

  2026-08-07

  The reference preprint shows that selected kinase inhibitors can do more than occupy the p38α catalytic site: they can also reshape the activation loop to accelerate its dephosphorylation by WIP1. Structural and biochemical evidence supports a conformation-directed strategy that may improve the specificity and durability of kinase inhibition, although its cellular and therapeutic relevance remains to be established.

• Network Pharmacology Reveals Apigenin’s Role in Alzheimer’s

  2026-08-07

  A recent network medicine study systematically identified flavonoids, highlighting Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) as a top candidate for modulating neuroprotection and inflammation in Alzheimer’s disease models. This article unpacks the study’s methodology, mechanistic insights, and translational relevance for experimental neurodegeneration research.

• Novobiocin Sodium: Bridging DNA Damage and Parasite Research

  2026-08-06

  Explore how Novobiocin Sodium empowers translational researchers to dissect DNA gyrase inhibition, map metabolic enzyme and apoptosis pathways, and pioneer anti-parasitic strategies. This thought-leadership article connects mechanistic insight with strategic workflow guidance, advancing the field beyond standard product pages.

• Refining In Vitro Drug Response Assessment in Cancer Researc

  2026-08-06

  Schwartz's dissertation establishes a new framework for distinguishing proliferative arrest from cell death in in vitro anti-cancer drug screening. This methodological advance clarifies drug mechanism assessment, improving the accuracy and interpretability of preclinical cancer research assays.

• Differential SHH Pathways in Penile Development: Guinea Pig

  2026-08-05

  Wang and Zheng's 2025 study reveals key species-specific differences in prepuce and urethral groove formation by analyzing SHH, Fgf10, and Fgfr2 expression in guinea pigs and mice. Their findings redefine our understanding of morphogen-driven penile development and highlight the translational relevance for congenital malformation research.

• Translating PTEN mRNA Innovations for PI3K/Akt Pathway Inhib

  2026-08-05

  This thought-leadership article explores the mechanistic and translational impact of advanced in vitro transcribed mRNA reagents, with a focus on EZ Cap™ Human PTEN mRNA (ψUTP) as a strategic tool for overcoming PI3K/Akt-driven cancer resistance. By synthesizing peer-reviewed studies and best-practice workflows, we provide actionable guidance for researchers seeking to leverage stable, immune-evasive mRNA for robust tumor suppressor gene restoration. The discussion critically evaluates the competitive landscape and clinical relevance, and concludes with an outlook on the maturation of mRNA therapeutics in precision oncology.

• Arrb2 Drives M2 Macrophage Polarization to Reduce Hepatic IR

  2026-08-04

  This study establishes that Arrb2 expression in hepatocytes promotes M2 macrophage polarization and attenuates hepatic ischemia–reperfusion injury via upregulation of the metabolite 6-ketoLCA. The findings illuminate a key hepatocyte–macrophage signaling axis and suggest new molecular targets for improving liver transplant outcomes.

• P2Y2 Receptor Activation Drives Microglial Clearance of Aβ42

  2026-08-04

  This article examines how nucleotides released from Aβ1–42-treated microglia enhance microglial migration and amyloid uptake via P2Y2 receptor activation, as shown in Kim et al.'s pivotal study. The findings illuminate a purinergic signaling mechanism that could be leveraged to improve amyloid clearance in Alzheimer's disease research and model systems.

• EZ Cap™ Human PTEN mRNA (ψUTP): Applied Workflows & Optimiza

  2026-08-03

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers robust, immune-evasive restoration of PTEN in cancer models, uniquely supporting resistance-reversal workflows via enhanced mRNA stability and translational efficiency. This article details practical delivery strategies, troubleshooting, and evidence-driven protocol tips for advanced translational research.

548 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page